Skip to main content
Log in

Angiographic appearance of patent saphenous vein grafts more than 25 years after coronary artery bypass grafting

  • Case Report
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Nine patients with ten angiographical patent saphenous vein grafts (SVG) more than 25 years after coronary artery bypass grafting (CABG) at Kawasaki Medical School Hospital between 1976 and 1992 were reviewed. Patent SVG disease was assessed using the FitzGibbon classification, and clinical characteristics which might affect the longevity of SVG were retrospectively evaluated. The mean duration between surgery and current coronary angiography was approximately 30 years (25–35 years). There were two perfectly patent SVGs (FitzGibbon AI, 35 and 32 years after surgery), both of which were bypass grafts to the left anterior descending arteries (LAD). The other eight grafts exhibited some vein graft disease (BII:3, BIII:5). The sequential anastomosis was performed for 5 SVGs. The SVGs bypassed to the good run-off LAD, sequential bypass, strict medical management including cessation of smoking and body weight control may contribute to the slow progression of vein graft disease after CABG.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. FitzGibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patient outcome: Angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–26.

    Article  CAS  Google Scholar 

  2. Furukawa H, Yamane N, Honda T, Yamasawa T, Kanaoka Y, Tanemoto K. Angiographic appearance of patent saphenous vein graft 32 years after coronary artery bypass grafting. Circ J. 2018. https://doi.org/10.1253/circj.CJ-18-0851.

    Article  PubMed  Google Scholar 

  3. ElBardissi AW, Aranki SF, Sheng S, O’Brien SM, Greenberg CC, Gammie JS. Trends in isolated coronary artery bypass grafting an analysis of the Society of Thoracic Surgeons adult cardiac surgery database. J Thorac Cardiovasc Surg. 2012;143:273–81.

    Article  Google Scholar 

  4. Japanese Association for Coronary Artery Surgery (JACAS). Coronary artery surgery results 2013, in Japan. Ann Thorac Cardiovasc Surg. 2014;20:332–4.

    Article  Google Scholar 

  5. Khot UN, Friedman DT, Pettersson G, Smedira NG, Li J, Ellis SG. Radial artery bypass grafts have an increased occurrence of angiographically severe stenosis and occlusion compared with left internal mammary arteries and saphenous vein grafts. Circulation. 2004;109:2086–91.

    Article  Google Scholar 

  6. Dreifaldt M, Mannion JD, Bodin L, Olsson H, Zagozdzon L, Souza D. The no-touch saphenous vein as the preferred second conduit for coronary artery bypass grafting. Ann Thorac Surg. 2013;96:105–11.

    Article  Google Scholar 

  7. Goldman S, Zadina K, Moritz T, Ovitt T, Sethi G, Copeland JG, et al. Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery. Results from a department of Veterans Affairs Cooperative Study. J Am Coll Cardiol. 2004;44:2149–56.

    Article  Google Scholar 

  8. Vural KM, Sener E, Tasdemir O. Long-term patency of sequential and individual saphenous vein coronary bypass grafts. Eur J Cardiothorac Surg. 2001;19:140–4.

    Article  CAS  Google Scholar 

  9. Motwani JG, Topol EJ. Aortocoronary saphenous vein graft disease—pathogenesis, predisposition, and prevention. Circulation 1998;97:916–31.

    Article  CAS  Google Scholar 

  10. Daida H, Yokoi H, Miyano H, Mokuno H, Satoh H, Kottke TE, et al. Relation of saphenous vein graft obstruction to serum cholesterol levels. J Am Coll Cardiol. 1995;25:193–7.

    Article  CAS  Google Scholar 

  11. The post coronary artery bypass graft trial investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997;336:153–62.

    Article  Google Scholar 

  12. Voors AA, van Brussel BL, Plokker HWT, Ernst SMPG, Ernst NM, Koomen EM, et al. Smoking and cardiac events after venous coronary bypass surgery. A 15-year follow-up study. Circulation. 1996;93:42–7.

    Article  CAS  Google Scholar 

  13. van Domburg RT, Meeter K, van Berkel DFM, Veldcamp RF, van Herwerden LA, Bogers AJJC. Smoking cessation reduces mortality after coronary artery bypass surgery: a 20-year follow-up study. J Am Coll Cardiol. 2000;36:878–83.

    Article  Google Scholar 

  14. Harskamp RE, Lopes RD, Baisden CE, de Winter RJ, Alexander JH. Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions. Ann Surg. 2013;257:824–33.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hiroshi Furukawa.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furukawa, H., Yamane, N., Honda, T. et al. Angiographic appearance of patent saphenous vein grafts more than 25 years after coronary artery bypass grafting. Gen Thorac Cardiovasc Surg 68, 177–180 (2020). https://doi.org/10.1007/s11748-018-1041-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-018-1041-8

Keywords

Navigation